Efficient production of recombinant cystatin C using a peptide-tag, 4AaCter, that facilitates formation of insoluble protein inclusion bodies in Escherichia coli.

Cystatin C is a cysteine protease inhibitor produced by a variety of human tissues. The blood concentration of cystatin C depends on the glomerular filtration rate and is an endogenous marker of renal dysfunction. Recombinant cystatin C protein with high immunogenicity is therefore in demand for the diagnostic market. In this study, to establish an efficient production system, a synthetic cystatin C gene was designed and synthesized in accordance with the codon preference of Escherichia coli genes. Recombinant cystatin C was expressed as a fusion with a peptide-tag, 4AaCter, which facilitates formation of protein inclusion bodies in E. coli cells. Fusion with 4AaCter-tag dramatically increased the production level of cystatin C, and highly purified protein was obtained without the need for complicated purification steps. The purity and yield of the final product was estimated as 87 ± 5% and 7.1 ± 1.1 mg/l culture, respectively. The recombinant cystatin C prepared by our method was as reactive against anti-cystatin C antibodies as native human cystatin C. Our results suggest that protein production systems using 4AaCter-tag could be a powerful means of preparing significant amounts of antigen protein.

[1]  L. Pearl,et al.  Recursive PCR: a novel technique for total gene synthesis. , 1992, Protein engineering.

[2]  J. Ghiso,et al.  Constitutive secretion of cystatin C (gamma-trace) by monocytes and macrophages and its downregulation after stimulation , 1987, The Journal of experimental medicine.

[3]  D. Keppler Towards novel anti-cancer strategies based on cystatin function. , 2006, Cancer letters.

[4]  A. Grubb,et al.  Inhibitory effects of recombinant human cystatin C on human coronaviruses , 1991, Antimicrobial Agents and Chemotherapy.

[5]  A. Grubb,et al.  Renal handling of radiolabelled human cystatin C in the rat. , 1996, Scandinavian journal of clinical and laboratory investigation.

[6]  A. Grubb,et al.  Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[7]  H. Sakai,et al.  Design and construction of a synthetic Bacillus thuringiensis Cry4Aa gene: Hyperexpression in Escherichia coli , 2008, Applied Microbiology and Biotechnology.

[8]  I. Heilberg,et al.  Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[9]  I. Olafsson,et al.  High-level expression of active human cystatin C in Escherichia coli. , 1989, Gene.

[10]  H. Sakai,et al.  Novel strategy for protein production using a peptide tag derived from Bacillus thuringiensis Cry4Aa , 2010, The FEBS journal.

[11]  E. Erlandsen,et al.  Serum Cystatin C as an Endogenous Marker of the Renal Function – a Review , 1999, Clinical chemistry and laboratory medicine.

[12]  A. Barrett,et al.  The disulphide bridges of human cystatin C (γ‐trace) and chicken cystatin , 1984 .

[13]  A. Kribben,et al.  Early detection of acute renal failure by serum cystatin C. , 2004, Kidney international.

[14]  V. Dharnidharka,et al.  Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  Y. Hori,et al.  Molecular cloning, expression in Escherichia coli, and development of monoclonal antibodies to feline cystatin C. , 2010, Veterinary immunology and immunopathology.

[16]  I. Olafsson,et al.  Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C , 1987, FEBS letters.

[17]  Akihiko Hirata,et al.  [Cystatin C]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[18]  G. Filler,et al.  Cystatin C as a marker of GFR--history, indications, and future research. , 2005, Clinical biochemistry.

[19]  Mutational analyses of Cry protein block7 polypeptides that facilitate the formation of protein inclusion in Escherichia coli , 2011, Applied Microbiology and Biotechnology.

[20]  L. Björck,et al.  Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus , 1990, Journal of virology.

[21]  J. Kos,et al.  Twenty-four hour variations of cystatin C and total cysteine proteinase inhibitory activity in sera from healthy subjects. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[22]  C. A. Thomas,et al.  Molecular cloning. , 1977, Advances in pathobiology.